CA76340/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	1
2001	3
2002	1
2003	2
2009	1
2010	2
2014	1
2015	1
2025	0

1

Cellular immunity to the Her-2/neu protooncogene.

Kiessling R, Wei WZ, Herrmann F, Lindencrona JA, Choudhury A, Kono K, Seliger B. Kiessling R, et al. Adv Cancer Res. 2002;85:101-44. doi: 10.1016/s0065-230x(02)85004-7. Adv Cancer Res. 2002. PMID: 12374283 Review.

2

Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination.

Gibson HM, Veenstra JJ, Jones R, Vaishampayan U, Sauerbrey M, Bepler G, Lum L, Reyes J, Weise A, Wei WZ. Gibson HM, et al. Cancer Immunol Res. 2015 Jul;3(7):777-86. doi: 10.1158/2326-6066.CIR-14-0175. Epub 2015 Feb 23. Cancer Immunol Res. 2015. PMID: 25711535 Free PMC article.

3

Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.

Radkevich-Brown O, Piechocki MP, Back JB, Weise AM, Pilon-Thomas S, Wei WZ. Radkevich-Brown O, et al. Cancer Immunol Immunother. 2010 Mar;59(3):409-17. doi: 10.1007/s00262-009-0760-1. Cancer Immunol Immunother. 2010. PMID: 19730859 Free PMC article.

4

Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity.

Veenstra JJ, Gibson HM, Littrup PJ, Reyes JD, Cher ML, Takashima A, Wei WZ. Veenstra JJ, et al. Cancer Res. 2014 Oct 1;74(19):5409-20. doi: 10.1158/0008-5472.CAN-14-0501. Epub 2014 Aug 4. Cancer Res. 2014. PMID: 25092895 Free PMC article.

5

Vaccination with cytoplasmic ErbB-2 DNA protects mice from mammary tumor growth without anti-ErbB-2 antibody.

Pilon SA, Piechocki MP, Wei WZ. Pilon SA, et al. J Immunol. 2001 Sep 15;167(6):3201-6. doi: 10.4049/jimmunol.167.6.3201. J Immunol. 2001. PMID: 11544306

6

Protection against mammary tumor growth by vaccination with full-length, modified human ErbB-2 DNA.

Wei WZ, Shi WP, Galy A, Lichlyter D, Hernandez S, Groner B, Heilbrun L, Jones RF. Wei WZ, et al. Int J Cancer. 1999 May 31;81(5):748-54. doi: 10.1002/(sici)1097-0215(19990531)81:5<748::aid-ijc14>3.0.co;2-6. Int J Cancer. 1999. PMID: 10328228

7

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial.

Norell H, Poschke I, Charo J, Wei WZ, Erskine C, Piechocki MP, Knutson KL, Bergh J, Lidbrink E, Kiessling R. Norell H, et al. J Transl Med. 2010 Jun 7;8:53. doi: 10.1186/1479-5876-8-53. J Transl Med. 2010. PMID: 20529245 Free PMC article. Clinical Trial.

8

Foreign antigenic peptides delivered to the tumor as targets of cytotoxic T cells.

Wei WZ, Ratner S, Shibuya T, Yoo G, Jani A. Wei WZ, et al. J Immunol Methods. 2001 Dec 1;258(1-2):141-50. doi: 10.1016/s0022-1759(01)00484-7. J Immunol Methods. 2001. PMID: 11684131

9

Human ErbB-2 (Her-2) transgenic mice: a model system for testing Her-2 based vaccines.

Piechocki MP, Ho YS, Pilon S, Wei WZ. Piechocki MP, et al. J Immunol. 2003 Dec 1;171(11):5787-94. doi: 10.4049/jimmunol.171.11.5787. J Immunol. 2003. PMID: 14634087

10

Degradation signals in ErbB-2 dictate proteasomal processing and immunogenicity and resist protection by cis glycine-alanine repeat.

Piechocki MP, Pilon SA, Kelly C, Wei WZ. Piechocki MP, et al. Cell Immunol. 2001 Sep 15;212(2):138-49. doi: 10.1006/cimm.2001.1853. Cell Immunol. 2001. PMID: 11748930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year